Abstract
The following review was constructed as a concept paper based on a recent workshop on neurodegenerative disease sponsored by the National Institute on Aging (NIA), the American Geriatric Society (AGS), and the John A. Hartford Foundation. The meeting was entitled “Thinking, moving and feeling: Common underlying mechanisms? 4th Annual Bedside-to-Bench Conference” and had the purpose to connect current basic and clinical findings on common brainrelated alterations occurring with aging such as depression, movement disorders, and cognitive decline. Many prominent researchers expressed their opinion on aging and it was revealed that age-related brain dysfunction of any kind seems to share several risk factors and/or pathways. But can something be done to actively achieve “successful aging”? In this review, based largely on the workshop and current literature, we have summarized some of the current theories for depression, movement and cognitive impairment with aging, as well as potential preventive measures. We have also summarized the emerging need for relevant animal models and how these could be developed and utilized.
Keywords: Neurodegeneration, memory, cognitive impairment, movement disorders, age-related depression, oxidative stress, neuroinflammation
Current Aging Science
Title: Mood, Memory and Movement: An Age-Related Neurodegenerative Complex?
Volume: 1 Issue: 2
Author(s): Ann-Charlotte Granholm, Heather Boger and Marina E. Emborg
Affiliation:
Keywords: Neurodegeneration, memory, cognitive impairment, movement disorders, age-related depression, oxidative stress, neuroinflammation
Abstract: The following review was constructed as a concept paper based on a recent workshop on neurodegenerative disease sponsored by the National Institute on Aging (NIA), the American Geriatric Society (AGS), and the John A. Hartford Foundation. The meeting was entitled “Thinking, moving and feeling: Common underlying mechanisms? 4th Annual Bedside-to-Bench Conference” and had the purpose to connect current basic and clinical findings on common brainrelated alterations occurring with aging such as depression, movement disorders, and cognitive decline. Many prominent researchers expressed their opinion on aging and it was revealed that age-related brain dysfunction of any kind seems to share several risk factors and/or pathways. But can something be done to actively achieve “successful aging”? In this review, based largely on the workshop and current literature, we have summarized some of the current theories for depression, movement and cognitive impairment with aging, as well as potential preventive measures. We have also summarized the emerging need for relevant animal models and how these could be developed and utilized.
Export Options
About this article
Cite this article as:
Granholm Ann-Charlotte, Boger Heather and Emborg E. Marina, Mood, Memory and Movement: An Age-Related Neurodegenerative Complex?, Current Aging Science 2008; 1 (2) . https://dx.doi.org/10.2174/1874609810801020133
DOI https://dx.doi.org/10.2174/1874609810801020133 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cellular and Molecular Mechanisms of Dementia: Decoding the Causal link of Diabetes Mellitus in Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Juvenile Delinquency and Challenges of Child and Adolescent Mental Health and Juvenile Justice in Japan
Adolescent Psychiatry SUBJECT INDEX
Current Neuropharmacology Myalgic Encephalomyelitis: Symptoms and Biomarkers
Current Neuropharmacology Steroid Regulation of Drug-Metabolizing Cytochromes P450
Current Drug Metabolism On the Biomaterials for Nanostructured Ocular Therapeutics
Current Organic Chemistry Sleepiness, Sleep Disorders and Attention-Deficit/Hyperactivity Disorder: Pathophysiological Rationale and Future Perspectives
Current Psychiatry Reviews Neuroprotective Role of Nutritional Supplementation in Athletes
Current Molecular Pharmacology Silymarin Extends Lifespan and Reduces Proteotoxicity in C. elegans Alzheimer’s Model
CNS & Neurological Disorders - Drug Targets Benzopentathiepine Derivative, 8-(Trifluoromethyl)-1,2,3,4,5-Benzopentathiepin- 6-Amine Hydrochloride (TC-2153), as a Promising Antidepressant of New Generation
Letters in Drug Design & Discovery Pharmacokinetic Evaluation of Callistemon viminalis Derived Natural Compounds as Targeted Inhibitors Against δ -Opioid Receptor and Farnesyl Transferase
Letters in Drug Design & Discovery Potential Effects of Cannabidiol as a Wake-Promoting Agent
Current Neuropharmacology The Links Between Sleep Apnea and Chronic Kidney Disease
Current Respiratory Medicine Reviews Possible Neuroprotective Strategies for Huntingtons Disease
Current Neuropharmacology Is a "Mitochondrial Psychiatry" in the Future? A Review
Current Psychiatry Reviews Adenosine and the Auditory System
Current Neuropharmacology Systematic Review of the Influence of Antipsychotics on the Blood Oxygenation Level-Dependent Signal of Functional Magnetic Resonance Imaging
Current Medicinal Chemistry The In Silico Drug Discovery Toolbox: Applications in Lead Discovery and Optimization
Current Medicinal Chemistry Mitochondria, Mitochondrial DNA and Alzheimers Disease. What Comes First?
Current Alzheimer Research Small Neuroscience: The Nanostructure of the Central Nervous System and Emerging Nanotechnology Applications
Current Nanoscience